The U.S. Food and Drug Administration has issued an emergency use authorization for a new novel coronavirus test from Abbott Laboratories. Results from the speedy test come back in as little as five ...
Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in diagnostics, which accelerated in the third quarter. Third-quarter revenue for its ...
The Food and Drug Administration issued a warning late Thursday over the accuracy of the highly-touted Abbott instant coronavirus test. Specifically, the FDA said that the test has caused some false ...
(Reuters) -Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, and the government's foreign ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. The maker of a rapid coronavirus test widely used across the United States and distributed by the federal government has warned ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results